Similar articles

• Prediagnostic plasma enterolactone levels and mortality among women with breast cancer.

  Olsen A, Christensen J, Knudsen KE, Johnsen NF, Overvad K, Tjønneland A. Olsen A, et al. Breast Cancer Res Treat. 2011 Aug;128(3):883-9. doi: 10.1007/s10549-011-1397-2. Epub 2011 Feb 22. Breast Cancer Res Treat. 2011. PMID: 21340481
• Serum enterolactone and prognosis of postmenopausal breast cancer.

  Buck K, Vrieling A, Zaineddin AK, Becker S, Hüsing A, Kaaks R, Linseisen J, Flesch-Janys D, Chang-Claude J. Buck K, et al. J Clin Oncol. 2011 Oct 1;29(28):3730-8. doi: 10.1200/JCO.2011.34.6478. Epub 2011 Sep 6. J Clin Oncol. 2011. PMID: 21900115
• Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.

  Zaineddin AK, Vrieling A, Buck K, Becker S, Linseisen J, Flesch-Janys D, Kaaks R, Chang-Claude J. Zaineddin AK, et al. Int J Cancer. 2012 Mar 15;130(6):1401-10. doi: 10.1002/ijc.26157. Epub 2011 Jul 21. Int J Cancer. 2012. PMID: 21544804
• [Phytoestrogenis properties of flaxseed lignans].

  Martinchik AN, Zubtsov VV. Martinchik AN, et al. Vopr Pitan. 2012;81(6):61-6. Vopr Pitan. 2012. PMID: 23530438 Review. Russian.
• Role of dietary lignans in the reduction of breast cancer risk.

  Saarinen NM, Wärri A, Airio M, Smeds A, Mäkelä S. Saarinen NM, et al. Mol Nutr Food Res. 2007 Jul;51(7):857-66. doi: 10.1002/mnfr.200600240. Mol Nutr Food Res. 2007. PMID: 17576639 Review.